Clinical safety and activity from a phase 1 study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions

2017 ◽  
Vol 72 ◽  
pp. S148 ◽  
Author(s):  
D.S. Hong ◽  
A. Dowlati ◽  
H.A. Burris ◽  
J.J. Lee ◽  
M.S. Brose ◽  
...  
2016 ◽  
Vol 27 ◽  
pp. ix46
Author(s):  
D.S. Hong ◽  
A. Dowlati ◽  
H.A. Burris ◽  
J.J. Lee ◽  
M.S. Brose ◽  
...  

2019 ◽  
Vol 111 (2) ◽  
pp. 536-547 ◽  
Author(s):  
Yung‐Jue Bang ◽  
Wu‐Chou Su ◽  
Martin Schuler ◽  
Do‐Hyun Nam ◽  
Wan Teck Lim ◽  
...  

2015 ◽  
Vol 4 (10) ◽  
pp. 1472-1483 ◽  
Author(s):  
Talia Golan ◽  
Tal Grenader ◽  
Patricia Ohana ◽  
Yasmine Amitay ◽  
Hilary Shmeeda ◽  
...  

Author(s):  
Marie O'Farrell ◽  
Richard Crowley ◽  
Timothy S. Heuer ◽  
Doug Buckley ◽  
Chris M. Rubino ◽  
...  

Author(s):  
Nuhad Ibrahim ◽  
Lucas Wong ◽  
Alison Stopeck ◽  
Lee S. Rosen ◽  
David E. Gerber ◽  
...  

2006 ◽  
Vol 12 (12) ◽  
pp. 3782-3791 ◽  
Author(s):  
Larry J. Schaaf ◽  
Lisa A. Hammond ◽  
Stuart J. Tipping ◽  
Richard M. Goldberg ◽  
Rakesh Goel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document